Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.
Deodhar S, Sillman B, Bade AN, Avedissian SN, Podany AT, McMillan JM, Gautam N, Hanson B, Dyavar Shetty BL, Szlachetka A, Johnston M, Thurman M, Munt DJ, Dash AK, Markovic M, Dahan A, Alnouti Y, Yazdi A, Kevadiya BD, Byrareddy SN, Cohen SM, Edagwa B, Gendelman HE.
Deodhar S, et al. Among authors: dyavar shetty bl.
Nat Commun. 2022 Jun 9;13(1):3226. doi: 10.1038/s41467-022-30902-7.
Nat Commun. 2022.
PMID: 35680875
Free PMC article.